Selank + Semax

What Is the Selank and Semax Combination?

Selank is a synthetic peptide developed from tuftsin, a naturally occurring immune-related peptide, and has been studied primarily for its calming, anxiety-reducing effects. Semax is a synthetic peptide developed from a fragment of ACTH, the hormone that normally triggers cortisol release, modified to retain effects on the nervous system while removing that hormonal activity. It's been studied primarily for stroke recovery and neuroprotection.

Both peptides were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and are approved as prescription medications in Russia, Selank for generalized anxiety disorder and neurasthenia, Semax for ischemic stroke recovery and certain cognitive conditions. Because their research focuses sit on different sides of brain function, one calming, one neuroprotective and cognition-supporting, researchers frequently pair them.

What This Combination is Being Researched For?

• Anxiety Reduction

  Selank's research base centers on anxiolytic effects, with a Russian clinical study finding effects comparable to a standard anxiolytic medication alongside additional benefits on fatigue.^[1]

• Neuroprotection and Cognitive Support

  Semax's research base centers on neuroprotection, with clinical evidence in acute stroke recovery and a proposed mechanism involving increased brain-derived neurotrophic factor (BDNF) levels.^[2]

• Combined Research Interest

  Because Selank's research focus is calming and anxiety-related while Semax's is neuroprotective and cognition-related, researchers pairing them are generally interested in whether addressing both angles together, calming the nervous system while supporting its underlying function, produces a more complete effect than either compound alone.

How the Combination Works

• Selank's Role

  Research points to Selank slowing the breakdown of the body's own enkephalin signaling molecules, while also influencing GABA, serotonin, and dopamine systems, which together are proposed to underlie its calming, anxiety-reducing effects.^[1]

• Semax's Role

  Research points to Semax increasing levels of brain-derived neurotrophic factor in relevant brain regions, without triggering the cortisol-releasing activity of full-length ACTH, which is the proposed basis for its neuroprotective research.^[2]

• Why They're Studied Together

  Since Selank's research base centers on calming inflammatory-adjacent stress signaling and Semax's centers on supporting neuron health and recovery, researchers pairing them are generally looking at whether the two distinct mechanisms complement each other across different aspects of brain function.

Reconstitution and Handling

Both peptides are typically supplied as a lyophilized powder in a sealed vial and reconstituted with bacteriostatic water before use in a research setting. Water should be added slowly rather than injected directly into the powder, and the vial should be swirled, not shaken.

Since the amount of water used affects the concentration of the final solution, researchers often use a dosage calculator to work this out for each peptide separately before mixing. Keel Bio's calculator is a commonly used tool for this. Once reconstituted, both solutions are kept refrigerated to help preserve stability.

Key Takeaways

Selank and Semax are paired because their individual research strengths address different sides of brain function: Selank for calming and anxiety, Semax for neuroprotection and recovery. Both carry genuine, if Russian-concentrated, clinical research histories and real regulatory approval in Russia. Most of what's published studies each peptide separately rather than in combination, so treat the pairing as a research-community practice built on complementary mechanisms rather than a body of combined-use data.

Frequently Asked Questions

Sources and Research

1. Zozulya AA, Neznamov GG, Siuniakov TS, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48.
2. Dolotov OV, Karpenko EA, Seredenina TS, et al. Semax, an analogue of adrenocorticotropin(4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain. J Neurochem. 2006;97(Suppl 1):82-86.